glp 1 drugs for perimenopause Let's talk about GLP-1 medications in the context of and menopause, because this is where the conversation most often gets flattened into something it is not. This is not about vanity GLP-1s For Perimenopause | Relief
Description
Following a thorough analysis of our previous Phase 2b data and trial design, we believe that with the preferred modified release formulation and future trial design optimization, we can advance a competitive oral GLP-1 molecule into registration enabling studies, with the goal of addressing the present and persistent medical needs of people living with obesity. Participants in the study so far have included healthy adults aged 18 years or older and the results thus far have shown a profile that supports once-daily dosing, which is consistent with previous danuglipron studies

66% of the platforms we reviewed offered compounded GLP-1s

GLP-1 helps this a lot
Reductions in body weight were progressive through the course of the study, with no plateau observed for weight loss at 13 weeks

An external solution of 140 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 2 mM EGTA, 10 mM HEPES, and 10 mM glucose, adjusted to pH 7.4 with NaOH, osmolarity 300310 mOsm, was used for both techniques
[1] For patients who experience milder abdominal symptoms that do not clearly indicate pancreatitis, contact your prescribing physician within 24 hours for guidance